Clinical Practice Guidelines for the Utilization of Positron Emission Tomography/Computed Tomography Imaging in Selected Oncologic Applications: Suggestions from a Provider Group Ken ManningBeth TepferRaghuveer Halkar Editorial 15 August 2007 Pages: 324 - 332
Etiopathologies Associated with Intercostal Muscle Hypermetabolism and Prominent Right Ventricle Visualization on 2-Deoxy-2[F-18]fluoro-d-glucose-Positron Emission Tomography: Significance of an Incidental Finding and in the Setting of a Known Pulmonary Disease Sandip BasuSaad AlzeairAbass Alavi Brief Article 03 July 2007 Pages: 333 - 339
Monitoring Response to Radiotherapy in Human Squamous Cell Cancer Bearing Nude Mice: Comparison of 2′-deoxy-2′-[18F]fluoro-d-glucose (FDG) and 3′-[18F]fluoro-3′-deoxythymidine (FLT) Carla F. M. MolthoffBianca M. KlabbersAdriaan A. Lammertsma Research Article Open access 21 July 2007 Pages: 340 - 347
Optimizing Dual-Time and Serial Positron Emission Tomography and Single Photon Emission Computed Tomography Scans for Diagnoses and Therapy Monitoring Joseph A. Thie Research Article 25 September 2007 Pages: 348 - 356
2-Deoxy-2-[F-18]fluoro-D-glucose Joint Uptake on Positron Emission Tomography Images: Rheumatoid Arthritis Versus Osteoarthritis E. H. ElzingaC. J. van der LakenA. E. Voskuyl Research Article Open access 28 September 2007 Pages: 357 - 360
Magnetic Resonance Imaging Based Bone Marrow Segmentation for Quantitative Calculation of Pure Red Marrow Metabolism Using 2-Deoxy-2-[F-18]fluoro-d-glucose- Positron Emission Tomography: a Novel Application with Significant Implications for Combined Structure–Function Approach Sandip BasuM. HouseniAbass Alavi Research Article 25 September 2007 Pages: 361 - 365